Roth MKM lowered the firm’s price target on eGain (EGAN) to $10 from $12 and keeps a Buy rating on the shares. The company’s Q2 results were fair, with revenues closely matching the firm’s forecast and earnings ahead of a soft guide, the analyst tells investors in a research note. Roth adds however that while doubling its seven-figure deal pipeline in six months is good, slower sales cycles and falling professional services leave revenue and earnings forecasts falling.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EGAN: